Welcome to our Translational Research arm, where we bridge the gap between groundbreaking scientific discoveries and real-world applications in bacterial and fungal healthcare. Our institution is dedicated to advancing the field of translational research, with a focus on innovative approaches to fungal vaccines, antibody therapy, immunotherapy, and molecular diagnostics.

Within our institute, researchers collaborate across disciplines to translate scientific insights into tangible solutions for patients and healthcare providers. Our work in fungal vaccines aims to develop preventive strategies that bolster the body’s defenses against various fungal pathogens, including multidrug-resistant Candida, Mucormycosis, Aspergillus etc., paving the way for proactive healthcare interventions.

Through antibody therapy, we target and neutralize fungal invaders with unparalleled specificity and efficacy. Our immunotherapy initiatives focus on enhancing the body’s innate ability to combat fungal infections, fostering rapid recovery, and reducing the risk of recurrence through immune modulation.

At the forefront of molecular diagnostics, our researchers leverage cutting-edge techniques to rapidly identify fungal species, characterize their genetic profiles, and guide personalized treatment decisions. By integrating advanced technologies such as polymerase chain reaction (PCR), we empower healthcare providers with timely and accurate diagnostic insights.

Our investigator’s webpages are a gateway to our ongoing research endeavors, providing access to resources, publications, and collaborations in translational fungal healthcare. We invite you to explore our multidisciplinary approach to advancing the frontiers of fungal research and clinical practice.